CMTR1 contributes to mRNA cap formation by methylating the O-2 position of the 1 st transcribed nucleotide ribose. mRNA cap O-2 methylation has roles in mRNA translation and self-RNA tolerance in innate immunity, however its role in cell physiology is unclear. We report that CMTR1 is recruited to Serine-5 phosphorylated RNA Pol II CTD, facilitating cotranscriptional methylation. We isolated CMTR1 in a complex with DHX15, an RNA helicase functioning in splicing and ribosome biogenesis, and characterised it as a regulator of CMTR1.
Introduction
Formation of the mRNA cap initiates the maturation of RNA pol II transcripts into translationcompetent mRNA (Furuichi, 2015) . The mRNA cap protects transcripts from degradation and recruits protein complexes involved in nuclear export, splicing, 3' processing and translation initiation (Ramanathan et al, 2016; Topisirovic et al, 2011) . mRNA cap formation initiates with the addition of an inverted guanosine group, via a tri-phosphate bridge, to the first transcribed nucleotide of nascent RNA pol II transcripts. Subsequently, this guanosine cap is methylated on the N-7 position to create the cap 0 structure, which binds efficiently to CBC, eIF4F and other complexes involved in RNA processing and translation initiation. The initial transcribed nucleotides are further methylated at several other positions, in a species-specific manner. In mammals, the O-2 position of the riboses of the 1 st and 2 nd transcribed nucleotides are sites of abundant methylation (Langberg & Moss, 1981) .
A series of enzymes catalyses mRNA cap formation, which have different configurations in different species (Shuman, 2002) . In mammals, RNGTT/CE catalyses guanosine cap addition and RNMT-RAM catalyses guanosine cap N-7 methylation. RNGTT/CE and RNMT-RAM are recruited to RNA pol II at the initiation of transcription (Buratowski, 2009 ). CMTR1 and CMTR2 methylate the O-2 position of 1 st and 2 nd transcribed nucleotides riboses, respectively (Belanger et al, 2010; Werner et al, 2011) . CMTR1 (ISG95, FTSJD2, KIAA0082) was first identified as a human-interferon regulated gene.
It was recognised to have several functional domains including a methyltransferase domain (Haline-Vaz et al, 2008) . Subsequently, CMTR1 was biochemically characterized as the O-2 ribose methyltransferase of the first transcribed nucleotide (Belanger et al, 2010) . Recently, the catalytic domain of CMTR1 was crystalized with s-adenosyl methionine and a capped oligonucleotide (Smietanski et al, 2014) . Our knowledge of the biological function of CMTR1 and 1 st nucleotide O-2 methylation is scant. An early report in sea urchin eggs demonstrated that following fertilization N-7 and O-2 cap methylation is associated with translational upregulation of a subset of maternal transcripts (Caldwell & Emerson, 1985) . During Xenopus oocyte maturation, 1 st nucleotide O-2 methylation significantly increases translation efficiency and is required for the translation of maternal mRNA (Kuge et al, 1998; Kuge & Richter, 1995) . In mice, a significant proportion of 1 st nucleotides were found to be O-2 methylated on the ribose, although the relative proportion of this methylation varied between organs, indicating a regulated event (Kruse et al, 2011) . O-2 methylation is likely to influence recruitment of cap binding complexes and promote ribosomal subunit binding (Muthukrishnan et al, 1976b) .
Recently, the composition of 5' cap has been identified as an important determinant of self (host) versus non-self (viral) RNA during viral infection (Leung & Amarasinghe, 2016) . The absence of O-2 methylation in viral transcripts was demonstrated to results in enhanced sensitivity to the interferon-induced IFIT proteins, which lead to the discovery that this first nucleotide methylation mark distinguishes self from non-self RNA (Daffis et al, 2010) . Schuberth-Wagner et al., provided the first evidence that CMTR1 is involved in the recognition of self RNA (Schuberth-Wagner et al, 2015) . CMTR1-dependent O-2 methylation of the first nucleotide abrogated activation of RIG-I, a helicase that initiates immune responses on interaction with uncapped or aberrantly capped transcripts. CMTR1 depletion was able to trigger a RIG-I-dependent immune response similar to that triggered by viral transcripts (Schuberth-Wagner et al, 2015) .
Here we report the first regulator of CMTR1 function. We report that CMTR1 and the DEAHbox RNA Helicase, DHX15, form a stable complex in cells and reciprocally influence each others activity and action. DXH15 restrains CMTR1 activity and localisation constraining first nucleotide methylation to a co-transcriptional event. CMTR1 impacts on DHX15 action by activating helicase activity and influencing nuclear localisation. Disruption of the CMTR1-DHX15 interaction leads to increased ribosome loading of a subset of mRNAs involved in key metabolic functions, which impacts on cell proliferation.
Results

CMTR1 interacts directly with DHX15
To investigate the regulation and function of CMTR1, we identified CMTR1-interacting proteins.
HA-CMTR1 was immunoprecipitated (IP) from HeLa cell extracts using anti-HA antibodies (Fig   1a) . IPs were resolved by SDS-PAGE and purified proteins identified by mass spectrometry. In HA-CMTR1 IPs, DHX15, a 95kDa DEAH box RNA helicase was identified (accession O43143), with significant mascot scores and protein coverage ( Fig EV1a) . In order to verify their interaction, GFP-CMTR1 and FLAG-DHX15 were transiently expressed in HeLa cells and coimmunoprecipitated from cell extracts (Fig1b) . In order to investigate the action of endogenous CMTR1, an antibody was raised against recombinant human CMTR1. In western blot analysis of HeLa cell extracts, the anti-CMTR1 antibody recognised an 110kDa band, the expected molecular weight of CMTR1, which was reduced following transfection of two independent CMTR1 siRNAs ( Fig EV1b) . IPs performed with the anti-CMTR1 antibody purified endogenous CMTR1 ( Fig EV1c) . The interaction of endogenous CMTR1 and DHX15 was confirmed by anti-CMTR1 and anti-DHX15 antibody IPs in HeLa, HCC1809, U2OS and HEK293 cell extracts, with species-matched IgG used as a negative control (Fig 1c) . In CMTR1 del cells, in which expression of guide RNAs and Cas9 ablated CMTR1 expression, the anti-CMTR1 antibody was unable to purify DHX15, discounting non-specific interactions of DHX15 with resin or antibody (Fig1d). Of note, inhibition of CMTR1 expression did not impact on DHX15 expression and, conversely, inhibition of DHX15 expression did not impact CMTR1 expression (Fig1d and   EV1b ). Since CMTR1 and DHX15 bind RNA the dependency of their interaction on RNA was investigated (Bohnsack et al, 2009; Smietanski et al, 2014) . The CMTR1-DHX15 interaction was sustained on RNaseA treatment and therefore is not maintained by an RNA connector (Fig 1e) .
RNaseA was confirmed to be functional by digestion of HeLa cell RNA ( Fig EV1d) . In HeLa cells, DHX15 and CMTR1 are expressed at equivalent molar ratio (Nagaraj et al, 2011) .
Equimolar recombinant human CMTR1 and His 6 -DHX15 co-immunoprecipitated, confirming their direct interaction (Fig 1f and EV1e) .
To gain insight into the relative abundance of CMTR1 and DHX15 complexes in HeLa cells, gel filtration analysis was performed (Fig 1g, upper panels) . Recombinant CMTR1 and His 6 -DHX15 monomers were also analysed, which migrated as expected for ~100kDa monomers (Fig 1g, lower panels). In HeLa cell extracts, approximately half of CMTR1 and DHX15 eluted at >670kDa, which is likely to contain the CMTR1-DHX15 complex. Approximately half of cellular CMTR1 also eluted at 100kDa, consistent with monomeric CMTR1. Analysis of HA-6 CMTR1 IPs indicated that the predominant CMTR1-interacting protein is DHX15 (Fig 1a) , and therefore in HeLa cells about half of cellular CMTR1 is in a DHX15-CMTR1 complex and half is in a CMTR1 monomer. Conversely, cellular DHX15 monomers were not observed, with DHX15 complexes peaking >670kDa and <670kDa, indicating two or more complexes. DHX15 is expected to migrate in several large complexes since it is also present in complexes associated with splicing and ribosomal biogenesis (Robert-Paganin et al, 2015) (Memet et al, 2017) . The relative abundance of DHX15 and CMTR1 complexes is likely to be different in different cell lines, depending on their abundance and that of other co-factors.
CMTR1 G-patch domain interacts with the DHX15 OB-fold
CMTR1 is an 835 residue protein possessing a nuclear localisation signal (residues 2-19), Gpatch domain (residues 85-133), RrmJ-type SAM-dependent O-2 methyltransferase domain (residues 170-550), guanylyltransferase-like domain (residues 560-729), and WW domain (755-790) (Fig 2a) (Aravind & Koonin, 1999; Belanger et al, 2010; Haline-Vaz et al, 2008; Smietanski et al, 2014) . To establish the regions of CMTR1 and DHX15 which interact, HeLa cells were transfected with N-terminal GFP-tagged CMTR1 wild type (WT) or mutants ∆N (25-835), ∆G (143-835), or GFP alone (Fig 2a) . Endogenous DHX15 coimmunoprecipitated with GFP-CMTR1 WT and mutants with the exception of GFP-∆G, the Gpatch deletion mutant (Fig 2b) . Furthermore, DHX15 co-immunoprecipitated with GFP-Gp, the G-patch domain of CMTR1 alone. GFP did not bind to DHX15.
DHX15 is a prototypic member of the DEAH family of RNA helicases (Jankowsky, 2011) . It contains a N-terminal domain of unknown function (residues 1-146), two Rec-A tandem repeats (residues 147-518), WH domain (residues 519-572), Ratched domain (residues 572-671), and OB-fold (residues 671-795) (Fig 2c) . The OB-fold is the predominant site of interaction with RNA and proteins, although the Rec-A domains can also establish functional interactions with RNA and protein (Lebaron et al, 2009 ). Other G-patch containing proteins have been demonstrated to interact with DHX15 via the OB-fold (Chen et al, 2014; Lin et al, 2009; Memet et al, 2017; Niu et al, 2012) . To study whether the DHX15 OB-fold is required for CMTR1 binding, N-terminal HA-tagged DHX15 WT or a C-terminal deletion mutant (1-635), ∆Cterm, were transiently expressed in HeLa cells. Endogenous CMTR1 immunoprecipitated with HA-DHX15 WT but not ∆Cterm (Fig 2d) .
G-patch domains have the consensus sequence, hhxxxGaxxGxGhGxxxxG, where "G" is glycine, "h" is a bulky, hydrophobic residue (I, L, V, M), "a" is an aromatic residue (F, Y, W), and "x" is any residue (Aravind & Koonin, 1999) . The CMTR1 G-patch has this consensus and in addition leucines at residues 94, 106 and 118 which are conserved in the G-patch domains of the established DHX15 interactors, PINX1, NKRF, GPATCH2, RBM5 (Fig 2e) (Chen et al, 2014; Lin et al, 2009; Memet et al, 2017; Niu et al, 2012) . Since these conserved leucines in other DHX15-binding proteins are required for the interaction, the impact of mutating CMTR1 L94, L106 and L118 to alanine was investigated using the 2L/A mutant (L94A and L106A), and the 3L/A mutant (L94A, L106A and L118A) (Fig 2e) . The 2L/A mutation was sufficient to abrogate the interaction of CMTR1 with DHX15 (Fig 2f) . This confirms that CMTR1 interacts with DHX15 through the G-patch domain.
DHX15 inhibits CMTR1 methyltransferase activity
To interrogate the biochemical function of the CMTR1-DHX15 complex, we investigated the impact of DHX15 on CMTR1 methyltransferase activity. A 32 P-guanosine-capped transcript was incubated with recombinant CMTR1 and methyl donor, SAM (s-adenosyl homocysteine) ( Fig   3a) . 1 st transcribed nucleotide O-2 methylation (GpppG to GpppGm conversion in our substrate) was observed by thin layer chromatography and quantitated by phosphoimager (Belanger et al, 2010 ATP did not alter DHX15-dependent repression of CMTR1 ( Fig EV3d) .
CMTR1 increases DHX15 helicase activity
We investigated the impact of CMTR1 on DHX15 ATPase and helicase activity (Figure 3e -h).
Established G-patch-containing DHX15 interactors have variable impact on ATPase activity (Lebaron et al, 2009; Tanaka et al, 2007) . Recombinant His 6 -DHX15 was incubated with a 32 P-ATP and hydrolysis visualised by the detection of a 32 P-ADP, which was resolved by thin layer chromatography and quantitated by phosphoimager (Fig 3e and f ). As established, addition of RNA significantly increased ATP hydrolysis (Fig 3e, f , EV3e, f, g) (Walbott et al, 2010) . In order to determine whether CMTR1 influenced DHX15-dependent ATP hydrolysis, a titration of recombinant CMTR1 was included in the ATPase assay. CMTR1 did not activate or repress 8 basal (Fig 3e and f) , or RNA-stimulated ATP hydrolysis ( Fig EV3h) . Addition of SAM had no impact on DHX15 ATP hydrolysis in the presence of CMTR1 or RNA ( Fig EV3i) .
Since interactors of Prp43, the yeast DHX15 homologue, have been demonstrated to regulate helicase activity independently of ATPase activity (Tanaka et al, 2007) , we investigated whether CMTR1 could regulate DHX15 helicase activity. A 32 P-DNA-RNA duplex was incubated with 1µM His 6 -DHX15. Helicase activity was confirmed by the loss of duplex in the presence but not absence of ATP ( Fig 3F, lanes 7 and 8) . When 0.1µM His 6 -DHX15 was used in this assay it exhibited minimal helicase activity (lane 3). Addition of CMTR1 increased helicase activity in a dose-dependent manner (lanes 4-6). CMTR1 alone had no helicase activity (lane 9).
DHX15 prevents CMTR1 recruitment to RNA pol II
CMTR1 interacts with RNA pol II, which is likely to permit efficient co-transcriptional 1 st nucleotide O-2 methylation (Haline-Vaz et al, 2008) . We investigated the impact of DHX15 on CMTR1 recruitment to RNA pol II. The interaction of recombinant CMTR1 and DHX15 with a biotinylated peptide consisting of three RNA pol II C-terminal domain heptad repeats (YSPTSPS) 3 , unphosphorylated (CTD) or phosphorylated on serine-5 (pCTD) was investigated (Fig4a-c). As a control, RNGTT was demonstrated to interact with pCTD but not CTD ( Fig   EV4a) (Ho & Shuman, 1999) . CMTR1 monomer bound to pCTD but not CTD (Fig 4a) , whereas His 6 -DHX15 monomer did not bind to either peptide (Fig 4b) . To investigate whether CMTR1
can recruit DHX15 to pCTD, the recombinant proteins were mixed prior to peptide pulldown.
Although CMTR1 and DHX15 interact in vitro (Fig 1f) , CMTR1 was recruited to pCTD whereas DHX15 was not, indicating that in DHX15-CMTR1 complexes DHX15 prevents CMTR1 recruitment to the pCTD (Fig 4c) .
The interaction of CMTR1 and DHX15 with RNA pol II was investigated in cells. In HeLa cells extracts, endogenous CMTR1 co-immunoprecipitated with RNA pol II phospho-Ser5-CTD (pSer5-CTD), but not RNA pol II phospho-Ser2-CTD (pSer2-CTD) or unphosphorylated RNA pol II (Fig 4d) . As expected, DHX15 was also present in the CMTR1 IPs. The interaction of CMTR1 and pSer5-CTD was RNaseA-insensitive and therefore RNA-independent ( FIG EV4b) .
To map the interaction of CMTR1 with RNA pol II, GFP-CMTR1 WT, 1-143, ∆G and ∆C (1-173), and HA-CMTR1, 2L/A and ∆C were transiently expressed in HeLa cells, immunoprecipitated via their tags and pSer5-CTD binding determined ( Fig. 4e and f). GFP-CMTR1 and HA-CMTR1 interacted with pSer5-CTD whereas GFP-CMTR1∆C and HA-9 CMTR1∆C did not, indicating that the WW domain mediates the interaction with RNA pol II ( Fig. 4e and f). GFP-CMTR1∆G and HA-CMTR1 2L/A (both defective for DHX15 binding)
interacted with pSer5-CTD, confirming that in cells DHX15 is not required for CMTR1 recruitment to RNA pol II ( Fig. 4 e and f ). Furthermore, siRNA-mediated suppression of DHX15 expression, did not impact on CMTR1 binding to pSer5-CTD ( Fig. 4g ).
Although DHX15 is not required for CMTR1 recruitment to pSer5-CTD (Fig 4a, c, e and f), it was important to determine whether in cells DHX15 binds to RNA pol II, either independently of or in a complex with CMTR1. HA-DHX15 was transiently expressed in HeLa cells and anti-HA IP performed (Fig 5h) . As expected, HA-DHX15 bound to CMTR1 but not to pSer5-CTD or unphosphorylated RNA pol II, confirming that in cells, as in vitro, DHX15 does not appreciably interact with RNA pol II (Fig. 4b , c and h). Furthermore this confirms in cells, as in vitro, that CMTR1 in a complex with DHX15 does not interact with RNA pol II ( Fig. 5c and h) . When the pSer-5-CTD was diminished using THZ1, a CDK7 inhibitor, DHX15 binding to CMTR1 was unaltered, contributing to the evidence that the DHX15-CMTR1 interaction is RNA pol IIindependent (Kwiatkowski et al, 2014) ( Fig. 4i ).
CMTR1 influences DHX15 localisation
Since DHX15 prevents CMTR1 interaction with RNA pol II, we investigated whether DHX15 influences CMTR1 subcellular localisation, which is predominantly nuclear ( resulted in partial cytoplasmic localisation, confirming that 14KKQKK contributes to CMTR1 nuclear localisation. In order to determine the impact of DHX15 on CMTR1 localisation, the localisation of GFP-CMTR1 3L/A, which does not bind DHX15, was investigated. GFP-CMTR1 3L/A was predominantly nuclear indicating that DHX15 does not influence CMTR1 localisation ( Fig 5a) . Furthermore, suppression of DHX15 expression did not alter CMTR1 nuclear localisation (Fig 5b) .
Since we had observed that CMTR1 stimulates DHX15 helicase activity in vitro, we investigated whether it also influences DHX15 localisation in cells. Prp43, the yeast homologue of DHX15, occupies several cellular locations to execute different biological functions (Heininger et al, 2016) . The different Prp43 locations are achieved by the competition of G-patch proteins, which recruit the helicase to different parts of the cell. In HeLa cells, DHX15 exhibited a diffuse nuclear localisation (Fig 5b and c) . However, in approximately a third of cells DHX15 also exhibited speckled nuclear foci, a common feature of splicing factors (Tannukit et al, 2009 ).
Indeed, DHX15 foci partially co-localized with the splicing factor SC35 (Pawellek et al, 2014) ( Fig EV5a) . The number of cell exhibiting DHX15 nuclear foci significantly increased when CMTR1 was knocked-down (Fig 5c and EV5b) , or transient transfection of guide RNAs and CRISPR/Cas9 (CMTR1 del cell line, Fig EV5c and d) .
DHX15 represses CMTR1-dependent translation
We had observed that DHX15 inhibits CMTR1-dependent O-2 methylation (Fig. 3 ), and interaction with RNA pol II (Fig. 4) , and that CMTR1 activates DHX15-dependent helicase activity ( Fig. 3 ) and controls DHX15 localisation (Fig. 5 ). The net outcome of these relationships is complex and will depend on many factors (see discussion). Here, we focussed our investigation on the impact of DHX15 on CMTR1 cellular function using the CMTR1 2L/A mutant, which does not bind to DHX15 (Fig. 2f ), but does to RNA pol II (Fig 4f) . Since 1 st nucleotide O-2 methylation is associated with enhanced translation (Kuge et al, 1998) , the impact of the DHX15-CMTR1 interaction on this process was investigated. HCC1806 cells were transfected with pcDNA5 HA-CMTR1 WT, 2L/A or vector control and polysome profiling analysis was performed, in which free ribosomes and ribosomal subunits are separated from translating ribosomes in a sucrose gradient (Fig 6a and b ). Although expression of CMTR1 WT and 2L/A had a mild impact on the polysome profiles, across multiple experiments the ratios between polysomes and monosomes were not significantly, indicating that DHX15 was not having a broad impact on translational control (Fig 6c) . To investigate gene-specific effects, RNA sequencing analysis was used to quantify total cellular transcripts and the transcripts associated with most dense ribosome binding (Fig 6a, shaded area ; Tables 1 and 2) . Out of 12238 gene transcripts that passed quality thresholds, none exhibited a significant difference in expression level in cells expressing CMTR1 WT and 2L/A (Table 1, Figure 6d ). This indicates that in HCC1806 cells, the CMTR1-DHX15 interaction is unlikely to have a significant impact on transcription or RNA stability. However, 59 genes were significantly enriched in polysomes in cells expressing CMTR1 2L/A compared to WT, indicating that the DHX15-CMTR1 interaction restricts the translation of a subset of mRNAs ( Fig. 6e and f; table 2). Conversely, no genes were significantly depleted from polysomes in cells expressing CMTR1 2L/A compared to WT, indicating that the DHX15-CMTR1 interaction does not enhance the translation of any mRNA.
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The genes which exhibited enhanced translation in cells expressing CMTR1 2L/A were enriched for GO terms associated with important metabolic functions and cell cycle processes (Table 3) .
Notably there was enrichment for genes encoding factors involved with the cell cycle and DNA damage responses including ATR, UBR4, UBR2, CENPE, PRKDC and BIRC6; factors involved in RNA processing including GCN1, TPR, RANBP2 and NUP205; metabolic enzymes including FASN, EPRS, and CAD; and focal adhesion-associated molecules HSPG2, FLNB, MYH9, FAT1, IGF2R, and CLTC. The polysome loading of selected genes was confirmed by RTPCR ( Fig. 6g ). Taken together this analysis indicates that DHX15 may repress the positive effect of CMTR1 on cell growth and proliferation.
The interaction of DHX15 and CMTR1 inhibits proliferation
The impact of CMTR1 expression on cell proliferation was investigated in HCC1806 cells and another mammary epithelial tumour line, MCF7. Transfection of two independent CMTR1 siRNAs resulted in suppression of CMTR1 expression and a reduction in cell proliferation ( Fig.   EV1b , 7a-c). Given that expression of CMTR1 2L/A resulted increased polysome loading of genes involved in metabolism and cell cycle, we investigated its impact on cell proliferation.
When HA-CMTR1 was transiently expressed in sparsely plated HCC1806 cells, a significant increase in cell number was observed after 24 hours ( Fig. 7d ). Transient expression of HA-CMTR1 2L/A resulted in a further increase in cell number, supporting the hypothesis that DHX15 suppresses the translation of a subset of pro-growth genes. To investigate if the increased expression of these genes may contribute to the enhanced proliferation observed on expression of CMTR1 2L/A, two genes with increased polysome loading in CMTR1 2L/A cells, CAD and GCN1, were suppressed by siRNA transfection (Fig. 7e ). Suppression of CAD and GCN1 resulted in reduced proliferation of HCC1806 cells, supporting the hypothesis that DHX15 controls CMTR1-dependent translation of a subset of pro-growth genes.
Discussion
Higher eukaryotes carry mRNA cap modifications not present in lower eukaryotes including O-2 methylation of the 1 st transcribed nucleotide ribose, which is associated with translation and the identification of self RNA in innate immunity (Kuge et al, 1998; Leung & Amarasinghe, 2016; Schuberth-Wagner et al, 2015) . Increased complexity of the mRNA capping enzymes is also observed in higher eukaryotes, including additional domains and subunits (Aregger & Cowling, 2013; Gonatopoulos-Pournatzis et al, 2011; Ramanathan et al, 2016; Shuman, 2002) . The additional complexity of the mammalian capping enzymes facilitates regulation of mRNA cap formation by cellular signaling pathways, which impacts on gene regulation and thus cell physiology and function (Aregger et al, 2016; Grasso et al, 2016) .
We investigated mechanisms regulating CMTR1, the 1 st nucleotide ribose O-2 methyltransferase (Belanger et al, 2010) . We isolated CMTR1 from HeLa cells as a monomer and in a complex with DHX15, a DEAH-box helicase involved in RNA processing, including splicing and ribosome biogenesis (Koodathingal & Staley, 2013; Robert-Paganin et al, 2015) . DHX15 lacks RNA-sequence specificity, but possess a C-terminal OB-fold through which it binds to a series of G-patch-containing proteins, allowing the helicase to contribute to several nuclear functions (Chen et al, 2014; Memet et al, 2017; Niu et al, 2012; Robert-Paganin et al, 2015; Tauchert et al, 2017) . CMTR1 contains a G-patch and we identified DHX15 as the predominant CMTR1interacting protein. Mutating two conserved leucines in the CMTR1 G-patch (2L/A mutant), was sufficient to abrogate interaction with DHX15. Previous studies had suggested that CMTR1 and DHX15 participate in the same mRNA processing events (Gebhardt et al, 2015; Yoshimoto et al, 2014 Previous studies demonstrated that O-2 methylation is associated with translation efficiency and promotes translation of oocyte maternal mRNAs (Kuge et al, 1998; Kuge & Richter, 1995; Muthukrishnan et al, 1976a) . In order to investigate the impact of DHX15 on CMTR1-dependent translation, the CMTR1 2L/A mutant (which does not bind to DHX15) was expressed, resulting in increased ribosome loading of a subset of transcripts. Therefore DHX15 restricts the translation of a specific subset of genes, which include those involved in metabolic pathways and cell cycle control. Expression of CMTR1 2L/A also resulted in increased cell proliferation.
The gene-specific impact of the DHX15-CMTR1 interaction parallels observations made following regulation of N-7 cap guanosine methylation; CDK1-dependent regulation of RNMT activity and ERK-dependent regulation of RAM expression both result in specific changes in gene expression, which influence cell proliferation and embryonic stem cell differentiation, respectively (Aregger et al, 2016; Grasso et al, 2016) . The mechanisms responsible for these gene-specific effects are currently unclear. The genes sensitive to the DHX15-CMTR1
interaction may be particularly dependent on O-2 methylation for polysome loading or these genes may require high levels of CMTR1 activity to be O-2 methylated.
CMTR1 controls DHX15 function
The mechanism by which G-patch proteins regulate DHX15 activity and localisation has been characterised for several other interactors. DHX15 uses energy generated by ATP hydrolysis to power helicase activity (Walbott et al, 2010) . ATPase activity, CMTR1 did not affect basal or RNA-stimulated DHX15 ATPase activity (Robert-Paganin et al, 2017) . A similar observation was made with the yeast splicing factor Ntr1, which did not alter Prp43 ATPase activity but did activate the helicase (Tanaka et al, 2007) .
Furthermore, although the G-patch is defined by well-conserved residues, there are now several examples of G-patch proteins impacting differentially on DHX15 activity and function (Aravind & Koonin, 1999; Banerjee et al, 2015; Tauchert et al, 2017) .
The competition of cofactors for DHX15 was previously observed to regulate its distribution between different pathways (Heininger et al, 2016) . DHX15 interacts with splicing factors, including TFIP11, and localises to nuclear splicing speckles (Tannukit et al, 2009 ). We also detected DHX15 co-localised with the splicing factor SC35 in nuclear speckles. Suppression of CMTR1 expression resulted in increased occurrence of DHX15 in nuclear speckles, indicating that CMTR1 also competes with other G-patch proteins for DHX15 binding.
Co-ordinated impact of DHX15 and CMTR1 on gene expression
Ultimately we want to understand how the relationship between DHX15 and CMTR1 impacts on cell physiology and function, which is complex due to the multifunctional nature of both enzymes. The cellular impact of the DHX15-CMTR1 interaction will depend on the relative expression of the enzymes and that of their other interacting partners, which also influence enzyme activity and localisation (e.g. pSer5-RNA pol II for CMTR1 and RNA processing factors for DHX15). The impact of the DHX15-CMTR1 interaction will also depend on the physiology of the cell, including the relative dependency on O-2 methylation, splicing, rRNA processing and translation. Therefore it is likely that the net outcome of the DHX15 and CMTR1 interaction will vary in different cell lineages and under different physiological circumstances.
Recently, somatic mutations of DHX15 were shown to be recurrent in the development of Core-Binding Factor Acute Myeloid Leukemia (CBF-AML). In particular, the missense DHX15-Arg 222 Gly mutation is present in ~5% of CBF-AML patients, both at diagnosis and/or disease relapse (Faber et al, 2016; Farrar et al, 2016; Sood et al, 2016) . DHX15-Arg222 is part of the RecA1-β-Turn RF conserved motif (Arginine-Phenylalanine), which is a key player in RNA translocation (Tauchert et al, 2017) . Interestingly, DHX15-R222G has reduced interaction with 15 proteins involved in splicing (TFP11), ribosomal biogenesis (NFRP) and translation (CMTR1), which may contribute the impact of the DHX15 mutant.
In summary, CMTR1 is regulated by DHX15 impacting on gene expression and cell physiology.
We now recognise that the mRNA capping enzymes, RNGTT, RNMT and CMTR1 are regulated by different co-factors and posttranslational modifications, with multiple impacts on gene expression and cell physiology. The challenge going forward is to understand the complex integration of these regulatory events during development and in the adult. 
Materials and Methods
Cell
Bacterial Expression and Purification of DHX15 and CMTR1 proteins
Bacterial expression plasmids pET15b-His 6 -DHX15 or pGEX6P1-GST-3C-CMTR1 transformed and chicken ovalbumin (44kDa). 
First nucleotide O-2 methylation assay
Molecular biology
cDNA cloning and mutagenesis performed by standard protocols. Constructs sequence-verified.
CTD peptide affinity chromatography
RNA pol-II CTD peptide chromatography performed as in (Ho & Shuman, 1999 
ATPase activity assay
ATPase reactions performed as in (Lebaron et al, 2009) 
Unwinding Assay
Unwinding assays performed as in (Tanaka et al, 2007 
Polysome profile
Cells incubated in 100 µg/ml cycloheximide for 10 min, washed in ice cold PBS supplemented with 100 µg/ml cycloheximide and extracts collected in polysome lysis buffer (15mM Tris (pH7.5), 15mM MgCl 2 , 0.3 M NaCl, 1 mM DTT, 1% Triton X-100, 100 mg/ml cycloheximide, 100 U/ml RNasin). 10% extracts retained as input and 90% resolved by centrifugation through 10 ml 10%-50% sucrose gradient at 18 000 x g for 2 hr at 4ºC. Fractions collected on FoxyR1 fractionator (TELEDINE ISCO) with OD259 nm monitoring.
RNA-sequencing and analysis
Extraction of polysomal RNA performed as described previously (Grasso et al, 2016 , 2010) . Genes with at least 1 count per million (CPM) in all samples analysed for differential expression. Pairwise comparisons made between input RNA and between polysomal RNA for samples transfected with pcDNA5, pcDNA 5 HA-CMTR1 WT or 2L/A. Plots comparing differential input or polysome mRNA abundance drawn using the ggplot2 R package.
RTPCR
RNA extracted using Trizol Reagent (Invitrogen). cDNA synthesised using iScript cDNA Synthesis Kit (Bio-Rad). RT-PCR performed using Quanta Biosciences SYBR Green. 
Primers
